NuCapCure

☀️ Summer is heating up and so is the science behind the future of cancer therapy. ✨ Beaming into Focus is back and this time we’re turning up the energy with reactor physics. From inspecting airplanes to powering medical breakthroughs, nuclear reactors do far more than most people imagine. In NuCapCure, they play a key role in generating the precisely tuned neutrons needed to activate our smart cancer-fighting compounds. ⚛️ Splitting atoms to generate controlled energy ⚡ Producing neutrons for next-generation targeted therapies 🔬 Supporting innovation in medicine, industry, archaeology, and environmental science This is where physics meets precision medicine, and where atomic science could help transform glioblastoma treatment. 🌞 So while the summer sun is beaming down, we’re continuing to beam into focus the science driving tomorrow’s therapies. 🚀 Explore the carousel to discover how reactor physics powers innovation far beyond the reactor itself. 👉 Follow NuCapCure for more behind-the-science insights and breakthrough research. 🌐 Visit our website to follow the journey from atomic interactions to therapeutic innovation: www.nucapcure.eu Thank you to our partners for making this series possible! Theo Theodossiou I UMCG I Universitetet i Oslo (UiO) | University of Oslo I Oslo University Hospital I Charles University I GalChimia I NCSR "DEMOKRITOS" I EURICE – European Research and Project Office GmbH I Centrum výzkumu Řež / Research Centre Řež I 1. lékařská fakulta UK

🧠 NuCapCure sparking discussion within the scientific community At the 20th Radiochemical Conference in Mariánské Lázně, Czech Republic, Daniela Veselá from project partner Centrum výzkumu Řež / Research Centre Řež presented NuCapCure through a poster contribution. 🔬 The presentation introduced NuCapCure’s approach to developing highly specific proton and neutron based therapies for glioblastoma, generating strong interest and valuable discussion among researchers attending the conference. 💬 The questions, exchanges, and feedback highlighted both the complexity of the challenge and the growing interest in innovative approaches for brain cancer treatment. 🔗 Curious to learn more about the project and follow our journey? Visit: www.nucapcure.eu #NuCapCure #Glioblastoma #CancerResearch #ProtonTherapy #NeutronTherapy #ScientificResearch #EUProjects

🧬 What if treating glioblastoma meant protecting the brain, not just attacking the tumour? In one of the most aggressive cancers known, where cells grow, adapt and resist at every turn, that shift in thinking could make all the difference. At NuCapCure, this is exactly the challenge we have set ourselves. By combining proton and neutron based therapies with smart radiopharmaceuticals, we aim to target tumour cells with precision, triggering powerful therapeutic reactions exactly where they are needed, while potentially harnessing the abscopal effect to recruit the immune system against the disease. ⚡Protons deliver energy at a defined depth, enabling accurate targeting and immunogenic cell death ⚡ Neutrons initiate reactions at the atomic level, also leading to immunogenic effects ⚡ Together, they activate compounds engineered to destroy cancer cells from within and may help unleash an immune response that hunts down what remains 🔬 Because beating cancer cannot be confined by disciplinary boundaries. 🚀 From atomic interactions to therapeutic innovation, we are forging new frontiers in cancer research. #NuCapCure #CancerResearch #Glioblastoma #Radiotherapy #WorldImmunologyDay

📍 Athens, Greece From 18–20 March, NuCapCure partners met for the project’s second progress meeting hosted by partner NCSR "DEMOKRITOS" marking the halfway point. 🧠 Discussions focused on advancing glioblastoma research, tackling current challenges, and defining the next steps for our proton- and neutron-based approaches. More than updates, the meeting was shaped by intensive exchange and problem-solving across disciplines. 🔗 What’s next for the project’s second phase? Read more: tinyurl.com/43nkuxe7 👉 Learn more about our research and follow the journey: www.nucapcure.eu #NuCapCure #Glioblastoma #CancerResearch #EUProjects #ResearchCollaboration

🚀 Opportunity within the NuCapCure network We’re excited to share that our partner UMCG is expanding their NuCapCure team with two open positions: 🔬 Postdoctoral Researcher Contribute to the validation of novel therapeutic compounds in glioblastoma models. Ideal for expertise in brain tumour biology, neuroscience, radiobiology, or in vivo modelling 🧪 Research Technician Support both in vitro and in vivo experiments, including histology, imaging, cell culture, and brain tumour models. 📅 Application deadline: April 15, 2026 🔗 Apply (Postdoc): https://lnkd.in/e7HERgVm 🔗 Apply (Technician): https://lnkd.in/e8wR3x4v ✨ At NuCapCure, collaboration across disciplines and institutions is key to driving breakthrough innovation. Opportunities like these are at the heart of building the teams that will shape the future of cancer treatment. 👉 If you would be a great fit or know someone who would be, learn more, tag them, and share this opportunity #NuCapCure #Glioblastoma #CancerResearch #ResearchJobs #Postdoc #Hiring #LifeSciences #Radiobiology #Neuroscience #EUProjects #EICPathfinder

NuCapCure is heading to Athens! From 18–20 March 2026, our partners will gather for the 2nd Progress Meeting. Three days of focused discussion, strategic alignment, and bold thinking. 🧠 As a high-risk, high-ambition project to revolutionise modern oncology through two ground-breaking proton and neutron treatments for glioblastoma, these moments matter. They are where disciplines connect, challenges are confronted, and the next phase of our journey takes shape. Athens provides the backdrop. Innovation drives the conversation. ⚡ 🔎 Want to learn more about what NuCapCure is working to achieve? Visit our website and follow our journey: www.nucapcure.eu #NuCapCure #EUResearch #HorizonEurope #CancerResearch #Innovation #ScientificCollaboration

🔬 What if the future of cancer therapy starts at the atomic level? ✨ Beaming into Focus continues and this week, we’re zooming in on proton and neutron physics. These aren’t just particles from a physics textbook. In NuCapCure, they become precision tools designed to act exactly where they’re needed: ⚡ Protons release their energy at a defined depth ideal for targeting tumours with accuracy ⚡ Neutrons interact directly with atomic nuclei, triggering powerful reactions ⚡ Together, they activate NuCapCure’s smart compounds to destroy cancer cells from within And their impact goes far beyond oncology. From advanced imaging to clean energy research, these particles are shaping tomorrow’s science. 🚀 Today’s beam is particle physics. Tomorrow’s breakthrough is precision therapy. 👉 Explore the carousel to see how NuCapCure transforms atomic interactions into therapeutic innovation. Up next: Reactor physics. Stay tuned! #NuCapCure #BeamingIntoFocus #ProtonTherapy #NeutronCapture #CancerResearch #Glioblastoma #HorizonEurope Thanks to the NuCapCure team for making this series possible: Theo Theodossiou I UMCG I Universitetet i Oslo (UiO) | University of Oslo | Oslo University Hospital I Charles University I GalChimia I NCSR "DEMOKRITOS" I EURICE – European Research and Project Office GmbH I Centrum výzkumu Řež / Research Centre Řež I 1. lékařská fakulta UK

🌍 In 2024, UNESCO called on the global community to close the gender gap in science. In 2025, we were invited to imagine a world with more women in science: #EveryVoiceInScience. In 2026, the focus shifts again. From reflection to action. From recommendations to real solutions that already work. At NuCapCure, we know that inclusive STEM ecosystems don’t happen by chance. They are built every day through conscious practices, supportive cultures, and collaborative teams. As researcher Daniela Veselá from our partner Centrum výzkumu Řež / Research Centre Řež puts it: “In our team, inclusion means everyone is heard before decisions are made, not just the most senior voice.” This principle is reflected in concrete practices that help create environments where people and science can thrive. Today, we celebrate not only women and girls in science, but the practices that make inclusive science possible and our team at NuCapCure who put them into action: Universitetet i Oslo (UiO) | University of Oslo I Oslo University Hospital I UMCG I GalChimia I NCSR "DEMOKRITOS" I EURICE – European Research and Project Office GmbH I 1. lékařská fakulta UK I Centrum výzkumu Řež / Research Centre Řež Because when more voices are heard, better science follows. 👇 Take a look at the carousel below to see how Daniela and her team make inclusion possible. Learn more about our work: www.nucapcure.eu #InternationalDayOfWomenAndGirlsInScience #WomenInScience #InclusiveSTEM #EveryVoiceInScience #ResearchCulture #NuCapCure

United by Unique. Stronger through science. 🧡 On World Cancer Day, we’re reminded that every cancer journey is different and that progress happens when research dares to think differently. At NuCapCure, we’re developing a new approach to one of the most aggressive brain cancers, glioblastoma. Instead of attacking from the outside, our researchers are exploring how tumour cells can be activated from within increasing precision while protecting healthy brain tissue. As part of our Behind the Breakthroughs series, we spoke with Robert Kaplanek from 1. lékařská fakulta UK, one of the researchers driving this work forward. In the interview, he shares: - Why glioblastoma urgently needs entirely new treatment strategies - How chemistry, imaging, and proton/neutron therapy come together in NuCapCure - Why progress depends not only on researchers but on society standing behind science “Glioblastoma is extremely aggressive. Without new treatment approaches, our chances of success are limited.” Today, we stand United by Unique: by patients, by science, and by the determination to do better. 👉 Read the full interview here: tinyurl.com/sbdstymk 🔬 Learn more about the NuCapCure project and how research is shaping the future of cancer therapy: www.nucapcure.eu #WorldCancerDay #UnitedByUnique #NuCapCure #BehindTheBreakthroughs #Glioblastoma

Together, we’re beaming new possibilities into cancer research. ✨ As 2025 comes to a close, the NuCapCure consortium reflects on a year of bold ideas, pioneering experiments, and unwavering collaboration across physics, chemistry, and biology. This year, our teams worked to advance two radical proton- and neutron-based therapies designed specifically for Glioblastoma multiforme (GBM). By harnessing the tumour’s own biosynthesis, our approaches aim to transform cancer cells into tiny intracellular chemistry labs, producing therapeutic agents from within while sparing healthy brain tissue. It’s ambitious. It’s disruptive. And it’s only possible because of the incredible partners and institutions who believe in pushing boundaries. 🚀 In 2026, we will continue beaming innovation directly into the heart of GBM research: deepening discoveries, expanding experiments, and moving closer to a new class of targeted cancer therapies. Thank you for being part of this journey. Here’s to a bright, promising, and breakthrough-filled new year. Let’s keep beaming forward together. 👉 Read more about our vision for the upcoming year: tinyurl.com/3a83m4ym #NuCapCure #CancerResearch #GBM #Glioblastoma #Innovation #NeutronTherapy #ProtonTherapy #EICPathfinder